Clinical Trial Update: Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial updating pazopanib in combination with capecitabine for metastatic breast cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Pazopanib (Pazopanib)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2014-09-18